Literature DB >> 6187472

Insertion of IS2 creates a novel ampC promoter in Escherichia coli.

B Jaurin, S Normark.   

Abstract

A class of ampC beta-lactamase-hyperproducing mutants of Escherichia coli were shown to have the insertion element IS2 inserted into the ampC promoter. The insertion of IS2 in orientation II created a novel promoter in which the -35 region and the 17 bp long spacing sequence between the two consensus sequences are present in IS2 DNA, whereas the -10 region from the original ampC promoter is retained. In vitro transcription revealed that the transcription initiation site in the ampC::IS2 mutants was identical with that of ampC wild-type promoter. The novel promoter exhibited a 20-fold increase in promoter strength relative to the original ampC promoter, presumably due to the increase in the spacing sequence from 16 to 17 bp. The evolution of transposable elements and of control elements such as promoters are discussed on the basis of the findings described herein.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6187472     DOI: 10.1016/0092-8674(83)90067-3

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  49 in total

1.  Constitutive activation of the fucAO operon and silencing of the divergently transcribed fucPIK operon by an IS5 element in Escherichia coli mutants selected for growth on L-1,2-propanediol.

Authors:  Y M Chen; Z Lu; E C Lin
Journal:  J Bacteriol       Date:  1989-11       Impact factor: 3.490

2.  The left end of IS2: a compromise between transpositional activity and an essential promoter function that regulates the transposition pathway.

Authors:  Leslie A Lewis; Edruge Cylin; Ho Kyung Lee; Robert Saby; Wilson Wong; Nigel D F Grindley
Journal:  J Bacteriol       Date:  2004-02       Impact factor: 3.490

3.  High-level expression of ampC beta-lactamase due to insertion of nucleotides between -10 and -35 promoter sequences in Escherichia coli clinical isolates: cases not responsive to extended-spectrum-cephalosporin treatment.

Authors:  L K Siu; Po-Liang Lu; J-Y Chen; F M Lin; Shan-Chwen Chang
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

4.  Nucleotide sequence analysis of Tn4551: use of ermFS operon fusions to detect promoter activity in Bacteroides fragilis.

Authors:  C J Smith
Journal:  J Bacteriol       Date:  1987-10       Impact factor: 3.490

5.  Identification, DNA sequence, and distribution of IS981, a new, high-copy-number insertion sequence in lactococci.

Authors:  K M Polzin; L L McKay
Journal:  Appl Environ Microbiol       Date:  1991-03       Impact factor: 4.792

Review 6.  Modes and modulations of antibiotic resistance gene expression.

Authors:  Florence Depardieu; Isabelle Podglajen; Roland Leclercq; Ekkehard Collatz; Patrice Courvalin
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

7.  Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals.

Authors:  Michael R Mulvey; Elizabeth Bryce; David A Boyd; Marianna Ofner-Agostini; Allison M Land; Andrew E Simor; Shirley Paton
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

8.  Complete maps of IS1, IS2, IS3, IS4, IS5, IS30 and IS150 locations in Escherichia coli K12.

Authors:  R P Birkenbihl; W Vielmetter
Journal:  Mol Gen Genet       Date:  1989-12

9.  Activation of a cryptic pathway for threonine metabolism via specific IS3-mediated alteration of promoter structure in Escherichia coli.

Authors:  B D Aronson; M Levinthal; R L Somerville
Journal:  J Bacteriol       Date:  1989-10       Impact factor: 3.490

10.  Molecular cloning and characterization of acrA and acrE genes of Escherichia coli.

Authors:  D Ma; D N Cook; M Alberti; N G Pon; H Nikaido; J E Hearst
Journal:  J Bacteriol       Date:  1993-10       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.